Search

everythinglearnresearchcommunity

for

Search:↓

Bone marrow and hair follicle cells help form skin tumors, suggesting new treatment targets.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

LGR5 and LGR6 are expressed differently in various skin tumors, which may offer clues about their origins.

Follicular mycosis fungoides can look like a B-cell lymphoma, making diagnosis difficult.

CD34+ hair follicle stem cells can become melanin-producing cells for treating skin conditions.

No CD44 in alopecia areata, present in normal and androgenetic alopecia.

A man developed autoimmune issues after a transplant, improved with treatment, but died from leukemia relapse.

The child was diagnosed with cutaneous leishmaniasis.

A small group of slow-growing cells causes basal cell carcinoma to return after treatment.

Lower proximal cup cells, not bulge stem cells, regenerate hair follicles after chemotherapy.

Increasing PDCD4 protein may help prevent or treat some skin cancers.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

A man with a type of skin lymphoma had unusual yellowish skin growths despite normal blood lipid levels, and treatment reduced some symptoms but not the growths.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

Early detection and infection prevention are crucial for improving survival in pediatric lupus patients with aplastic anemia.

Discoid lupus erythematosus involves immune activation and fibrosis around hair follicles, with shared pathways across humans, dogs, and mice, suggesting potential treatments for both humans and animals.

Removing certain immune cells in mice causes their hair to enter the growth phase earlier than usual.

Both VEPA and ML-Y1 treatments are not effective enough for elderly non-Hodgkin's lymphoma patients.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Alopecia areata is linked to blood cancers, especially in older patients, but not to most solid cancers.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

Nab-paclitaxel chemotherapy can rarely cause lupus-like skin issues.

Highly active but fewer CD14+CD16- monocytes are found in Alopecia Areata patients, regardless of severity.